|
SOURCE: Xtalks
|
|
SOURCE: Xtalks
|
May 16, 2017 07:30 ET
TORONTO, ON--(Marketwired - May 16, 2017) - Mia Kobuta, Manager, Logistics Client Services from Sharp Clinical Services Inc. and Will Plyler, Manager of Business Development -- Clinical Research Services from McKesson Specialty Pharmacy Solutions will discuss the key aspects of a DTP program and how it works -- protocol development, clinical manufacturing/packaging, fulfillment/distribution, logistics/tracking and maintaining compliance -- with an eye to determining the trials for which it might work and choosing the best partner to support your clinical trial. The live broadcast takes place on Monday, June 5, 2017 at 11am EDT (4pm BST/UK).
Patient enrollment is one of the most critical variables in a successful clinical trial. For drug therapies that are focused on an elderly patient population and the critically ill, sponsors and contract research organizations are increasingly turning to direct-to-patient (DTP) distribution strategies for their clinical trial design. In certain situations, DTP trials can reduce the patients' need to travel to the clinical site and can potentially contribute to improved patient recruitment and retention over traditional drug distribution strategies.
DTP trials are fast becoming a key clinical trial solution within certain patient populations and trials. Choosing a provider with comprehensive capabilities, the necessary infrastructure, a broad background of experience and a culture of problem-solving flexibility can help to both accelerate your study and reduce study costs.
In this webinar, viewers will learn:
In many ways, your clinical manufacturer and packaging partner is a key link to a successful DTP program. By choosing a company with a comprehensive range of services, you'll be able to manage your entire supply chain, including packaging and labeling of the investigational product and clinical support services, with a single provider and under one roof. A clinical manufacturer and packager with experience in conducting DTP studies will help you develop an appropriate protocol and distribution strategy, which can both mitigate risks and drive better outcomes.
For a DTP trial, it's important that your partner has manufacturing, packaging, and clinical support services. They should be able to design, assemble and label patient kits in a customized fashion to satisfy your clinical trial needs. Furthermore, your CMO should work to develop an optimal carrier and distribution approach that is customized based on your drug's temperature requirements, the size of the individual kits, the nature of the material and the frequency of dispatches to the patient's home.
To learn more about this event visit: Choosing the Right Partner to Build a Successful Direct-to-Patient (DTP) Clinical Trial Framework
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Image Available: http://www.marketwire.com/library/MwGo/2017/5/15/11G138887/Images/SharpClinical_logo-ffce0ff014449c1899d97ac40f9b9f2e.jpg
